Evaluation of a genetic risk score for severity of COVID-19 using human chromosomal-scale length variation

Human Genomics

James P. Brody¹  Christopher Toh¹ 

[1] Department of Biomedical Engineering, University of California, Irvine, USA;

关键词: COVID-19;    Genetic risk score;    UK biobank;    Machine learning;   

DOI  :  10.1186/s40246-020-00288-y

来源: Springer

【 摘 要 】

IntroductionThe course of COVID-19 varies from asymptomatic to severe in patients. The basis for this range in symptoms is unknown. One possibility is that genetic variation is partly responsible for the highly variable response. We evaluated how well a genetic risk score based on chromosomal-scale length variation and machine learning classification algorithms could predict severity of response to SARS-CoV-2 infection.MethodsWe compared 981 patients from the UK Biobank dataset who had a severe reaction to SARS-CoV-2 infection before 27 April 2020 to a similar number of age-matched patients drawn for the general UK Biobank population. For each patient, we built a profile of 88 numbers characterizing the chromosomal-scale length variability of their germ line DNA. Each number represented one quarter of the 22 autosomes. We used the machine learning algorithm XGBoost to build a classifier that could predict whether a person would have a severe reaction to COVID-19 based only on their 88-number classification.ResultsWe found that the XGBoost classifier could differentiate between the two classes at a significant level (p = 2 · 10−11) as measured against a randomized control and (p = 3 · 10−14) as measured against the expected value of a random guessing algorithm (AUC = 0.5). However, we found that the AUC of the classifier was only 0.51, too low for a clinically useful test.ConclusionGenetics play a role in the severity of COVID-19, but we cannot yet develop a useful genetic test to predict severity.

【 授权许可】

CC BY